1. Home
  2. ABEO vs PHT Comparison

ABEO vs PHT Comparison

Compare ABEO & PHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • PHT
  • Stock Information
  • Founded
  • ABEO 1974
  • PHT 2002
  • Country
  • ABEO United States
  • PHT United States
  • Employees
  • ABEO N/A
  • PHT N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • PHT Investment Managers
  • Sector
  • ABEO Health Care
  • PHT Finance
  • Exchange
  • ABEO Nasdaq
  • PHT Nasdaq
  • Market Cap
  • ABEO 256.9M
  • PHT 231.2M
  • IPO Year
  • ABEO 1980
  • PHT N/A
  • Fundamental
  • Price
  • ABEO $6.24
  • PHT $7.93
  • Analyst Decision
  • ABEO Strong Buy
  • PHT
  • Analyst Count
  • ABEO 5
  • PHT 0
  • Target Price
  • ABEO $17.80
  • PHT N/A
  • AVG Volume (30 Days)
  • ABEO 1.7M
  • PHT 85.5K
  • Earning Date
  • ABEO 05-15-2025
  • PHT 01-01-0001
  • Dividend Yield
  • ABEO N/A
  • PHT 8.76%
  • EPS Growth
  • ABEO N/A
  • PHT N/A
  • EPS
  • ABEO N/A
  • PHT 0.98
  • Revenue
  • ABEO N/A
  • PHT N/A
  • Revenue This Year
  • ABEO N/A
  • PHT N/A
  • Revenue Next Year
  • ABEO $383.07
  • PHT N/A
  • P/E Ratio
  • ABEO N/A
  • PHT $7.71
  • Revenue Growth
  • ABEO N/A
  • PHT N/A
  • 52 Week Low
  • ABEO $3.93
  • PHT $6.41
  • 52 Week High
  • ABEO $7.32
  • PHT $7.60
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 56.57
  • PHT 62.77
  • Support Level
  • ABEO $5.93
  • PHT $7.87
  • Resistance Level
  • ABEO $7.17
  • PHT $7.93
  • Average True Range (ATR)
  • ABEO 0.44
  • PHT 0.09
  • MACD
  • ABEO -0.01
  • PHT -0.00
  • Stochastic Oscillator
  • ABEO 50.00
  • PHT 71.43

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About PHT Pioneer High Income Fund Inc.

Pioneer High Income Trust is a closed-end management investment company. Its investment objective is to provide a high level of current income and to seek capital appreciation by investing predominantly in below investment grade (high-yield) debt securities, loans, and preferred stocks.

Share on Social Networks: